3-azidopyrimethamine has been researched along with Sarcoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blackledge, G; Fuchs, R; Keizer, HJ; Kerbrat, P; Rankin, E; Somers, R; Sylvester, R; Thomas, D; van Oosterom, A; Verweij, J | 1 |
1 other study(ies) available for 3-azidopyrimethamine and Sarcoma
| Article | Year |
|---|---|
A phase II study of M-azido-pyrimethamine ethane sulphonate (MZPES) in advanced, recurrent soft tissue sarcoma. An EORTC Soft Tissue and Bone Sarcoma Group Study.
Topics: Adult; Aged; Azides; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Pyrimethamine; Sarcoma; Soft Tissue Neoplasms | 1989 |